SEC Form SC 13D/A filed by Viemed Healthcare Inc. (Amendment)
$VMD
Misc Health and Biotechnology Services
Health Care
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a)
(Amendment No. 1)1
| Viemed Healthcare, Inc. | ||
(Name of Issuer)
Common Shares, No Par Value | ||
(Title of Class of Securities)
| 92663R105 | ||
(CUSIP Number)
Michael Moore
625 E. Kaliste Saloom Rd.
Lafayette, Louisiana 70508
(337) 504-3802
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
| May 18, 2023 | ||
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box: ☐
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
1The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
1
1. | NAMES OF REPORTING PERSONS Michael Moore | ||||||||||||||||||||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | (a) | ☐ | ||||||||||||||||||||
| (b) | ☒ | ||||||||||||||||||||||
| 3. | SEC USE ONLY | ||||||||||||||||||||||
| 4. | SOURCE OF FUNDS (SEE INSTRUCTIONS) OO | ||||||||||||||||||||||
| 5. | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) | ||||||||||||||||||||||
| 6. | CITIZENSHIP OR PLACE OF ORGANIZATION United States | ||||||||||||||||||||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7. | SOLE VOTING POWER | 2,421,319 | ||||||||||||||||||||
| 8. | SHARED VOTING POWER | 0 | |||||||||||||||||||||
| 9. | SOLE DISPOSITIVE POWER | 2,421,319 | |||||||||||||||||||||
| 10. | SHARED DISPOSITIVE POWER | 0 | |||||||||||||||||||||
| 11. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,421,319 shares of Common Stock | ||||||||||||||||||||||
| 12. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ☐ | |||||||||||||||||||||
| 13. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.3%2 | ||||||||||||||||||||||
| 14. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN | ||||||||||||||||||||||
2Assumes 38,276,389 Common Shares of the Company outstanding as of April 27, 2023, as reflected in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023, filed with the SEC on May 8, 2023.
2
Item 1. Security and Issuer.
This Amendment No. 1 (“Amendment No. 1”) amends the Schedule 13D initially filed on February 12, 2021 and is filed to report changes in the beneficial ownership of Common Shares by Michael Moore. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.
Item 5. Interest in Securities of the Issuer.
Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:
| (a) – (b) | The percent of class provided for Moore is made in accordance with Rule 13d-3(d) of the Securities Act of 1933, as amended (the “Securities Act”) and is based on 38,276,389 Common Shares outstanding as of April 27, 2023, as reflected in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023, filed with the SEC on May 8, 2023. Moore is the beneficial owner of 2,421,319 Common Shares, which amount includes 603,298 shares issuable upon the exercise of options that are vested or will vest within 60 days. Moore has the sole power to vote or to direct the vote of and the sole power to dispose of or to direct the disposition of 2,421,319 Common Shares. Moore shares the power to vote or to direct the vote of or to dispose or to direct the disposition of zero Common Shares. The information provided on the cover pages with respect to the beneficial ownership of Moore is incorporated herein by reference. | |||||||
3
| (c) | On January 4, 2021, an award of 99,243 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 30,917 Common Shares to satisfy Moore’s tax obligation resulting from the vesting of the 99,243 restricted share units. On January 4, 2021, an award of 43,513 stock options awards granted to Moore vested. On January 17, 2021, an award of 121,299 stock options awards granted to Moore vested. On January 21, 2021, Moore received a grant of 120,584 options to acquire Common Shares under the 2020 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 17, 2022, an award of 121,299 stock options awards granted to Moore vested. On January 18, 2022, Moore received a grant of 85,410 options to acquire Common Shares and 56,937 restricted stock units under the 2020 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 21, 2022, an award of 40,195 stock options awards granted to Moore vested. On January 17, 2023, Moore received a grant of 80,818 restricted stock units under the 2020 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 17, 2023, an award of 52,224 stock options awards granted to Moore vested. On January 18, 2023, an award of 28,470 stock options awards granted to Moore vested and an award of 18,979 restricted share units granted to Moore vested which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 6,767 Common Shares to satisfy Moore’s tax obligation resulting from the vesting of the 18,979 restricted share units. On January 21, 2023, an award of 40,195 stock options awards granted to Moore vested. | |||||||
| (d) – (e) | Not applicable | |||||||
4
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: May 18, 2023
/s/ Michael Moore
Michael Moore
5